The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes.
The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients.
[Effect of tongmal recipe on atherosclerosis in patients with early lower extremity arteriopathy caused by type 2 diabetes mellitus].
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial.
Caruso P, Maiorino MI, Longo M, Porcellini C, Matrone R, Digitale Selvaggio L, Gicchino M, Carbone C, Scappaticcio L, Bellastella G, Giugliano D, Esposito K.
JAMA Netw Open. 2024 Mar 4;7(3):e241545. doi: 10.1001/jamanetworkopen.2024.1545.
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
Mahé G, Aboyans V, Cosson E, Mohammedi K, Sarlon-Bartoli G, Lanéelle D, Mirault T, Darmon P.
Cardiovasc Diabetol. 2024 Jun 26;23(1):220. doi: 10.1186/s12933-024-02325-9.
Neutrophil-to-lymphocyte ratio in type 2 diabetes patients combined with Lower Extremity Peripheral Artery Disease.
Li L, Wang M, Jia T, Jiang X, Yang F, Wang Z, Zhang X.
Front Endocrinol (Lausanne). 2024 Aug 30;15:1434580. doi: 10.3389/fendo.2024.1434580. eCollection 2024.
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes.
Bonaca MP, Catarig AM, Hansen Y, Houlind K, Ramesh CK, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Verma S.
Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11;10(8):728-737. doi: 10.1093/ehjcvp/pvae071.
Risk of lower extremity amputation in patients with type 2 diabetes mellitus and peripheral arterial disease receiving sodium-glucose cotransporter-2 inhibitors versus other medications: A systematic review and meta-analysis of observational cohort studies.
Hodgson A, Gillies CL, Highton P, Haddon L, Gharibzadeh S, Zaccardi F, Khunti K.
Diabetes Obes Metab. 2024 Jun;26(6):2487-2491. doi: 10.1111/dom.15571. Epub 2024 Apr 1.
Impact of Diabetes on Outcomes of Patients With Lower Extremity Artery Disease.
Behrendt CA, Lareyre F, Raffort J.
Angiology. 2022 Jul;73(6):493-494. doi: 10.1177/00033197221074413. Epub 2022 Feb 9.
Increased Serum WISP1 Levels are Associated with Lower Extremity Atherosclerotic Disease in Patients with Type 2 Diabetes Mellitus.
Cheng Y, Du X, Zhang B, Zhang J.
Exp Clin Endocrinol Diabetes. 2022 Apr;130(4):248-253. doi: 10.1055/a-1474-8220. Epub 2021 Apr 30.
Cholesterol-Lowering Agents.
Rosenson RS, Hegele RA, Koenig W.
Circ Res. 2019 Feb;124(3):364-385. doi: 10.1161/CIRCRESAHA.118.313238.
Sex-influenced association of metabolic syndrome with lower extremity arterial disease in type 2 diabetes.
Chen Q, Zhu H, Shen F, Zhang X, Xu Z, Ran X, Ji L.
J Diabetes Complications. 2020 May;34(5):107537. doi: 10.1016/j.jdiacomp.2020.107537. Epub 2020 Jan 18.
Association of Lower Extremity Vascular Disease, Coronary Artery, and Carotid Artery Atherosclerosis in Patients with Type 2 Diabetes Mellitus.
Yang Z, Han B, Zhang H, Ji G, Zhang L, Singh BK.
Comput Math Methods Med. 2021 Oct 16;2021:6268856. doi: 10.1155/2021/6268856. eCollection 2021.
